| pubmed-article:17149493 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0038435 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0016410 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0019878 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0035253 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:17149493 | lifeskim:mentions | umls-concept:C2348867 | lld:lifeskim |
| pubmed-article:17149493 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17149493 | pubmed:dateCreated | 2006-12-6 | lld:pubmed |
| pubmed-article:17149493 | pubmed:abstractText | Hyperhomocysteinaemia (Hhcy) is known to be an independent risk factor for vascular disease. Coronary flow reserve (CFR) measured by positron emission tomography (PET) is a sensitive method to monitor the effects of pharmacologic interventions in Hhcy. We assessed coronary vascular reactivity by PET in patients with coronary artery disease (CAD) dependent on their homocysteine (Hcy) levels before and under high dose folic acid supplementation therapy (FAST). | lld:pubmed |
| pubmed-article:17149493 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17149493 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17149493 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17149493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17149493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17149493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17149493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17149493 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17149493 | pubmed:issn | 0029-5566 | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:MaurerGG | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:DudczakRR | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:KletterKK | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:GrafSS | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:HuberKK | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:PirichCC | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:NekollaSS | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:NikfardjamMM | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:KhorsandAA | lld:pubmed |
| pubmed-article:17149493 | pubmed:author | pubmed-author:OfluogluSS | lld:pubmed |
| pubmed-article:17149493 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17149493 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:17149493 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17149493 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17149493 | pubmed:pagination | 248-53 | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:meshHeading | pubmed-meshheading:17149493... | lld:pubmed |
| pubmed-article:17149493 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17149493 | pubmed:articleTitle | 13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels. | lld:pubmed |
| pubmed-article:17149493 | pubmed:affiliation | Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. senta.graf@meduniwien.ac.at | lld:pubmed |
| pubmed-article:17149493 | pubmed:publicationType | Journal Article | lld:pubmed |
